Neurovascular devices are medical instruments used to treat various neurological disorders, injuries or infections affecting the blood vessels that supply the brain and spinal cord. Some key advantages include faster recovery time, minimally invasive procedures and improved health outcomes. Rising cases of strokes, aneurysms, arteriovenous malformations and carotid artery disease have increased the need for effective neurovascular treatments, driving demand for neurovascular devices.

The neurovascular devices market is estimated to be valued at US$ 3.05 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024-2031.

Key Takeaways
Key players operating in the Neurovascular Devices Market are 3M, Convatec Group PLC, Smith & Nephew PLC, Urgo Medical, and Coloplast Corporation, among others. The key players are investing heavily in R&D to develop innovative product offerings and consolidate their market position. Growing prevalence of neurovascular disorders and increasing patient awareness about available treatment options have amplified demand for neurovascular devices. Technological advancements like flow diverters, liquid embolics and coil assist devices have made neurovascular procedures more effective and less risky for patients.

The Asia Pacific region has emerged as the fastest growing market for neurovascular devices in recent years and is expected to continue on its growth trajectory. Increasing awareness about management of neurological disorders, growing healthcare expenditures of nations, large patient pools due to bigger population size offer immense scope for market expansion. In addition, growing penetration of major multinational device companies Point towards bright prospects. China and India dominate the Asia Pacific neurovascular devices landscape.

Get more insights on Neurovascular Devices Market